Company news

Noxopharm Ltd. news in 2025

Noxopharm Ltd.'s news releases, calls and decks from 2025, newest first.

View company

HERACLES clinical trial Update 5

December 2, 2025

First dose in HERACLES clinical trial Part Two

November 16, 2025

Second part of HERACLES clinical trial begins

November 4, 2025

September 2025 Quarterly Activities Report and Appendix 4C

October 29, 2025

First US patent for Sofra technology platform

October 21, 2025

Extension of Convertible Notes and Funding

September 22, 2025

HERACLES clinical trial Update 4

September 7, 2025

Appendix 4E Preliminary Final Report

August 28, 2025

HERACLES clinical trial Update 3

August 24, 2025

HERACLES clinical trial Update 2

August 10, 2025

US company demonstrates strong Sofra potential

August 4, 2025

June 2025 Quarterly Activities Report and Appendix 4C

July 29, 2025

HERACLES clinical trial - Update 1

July 28, 2025

First SOF-SKN dose in HERACLES clinical trial

July 15, 2025

Promising Sofra results from overseas company

June 11, 2025

Green light for HERACLES clinical trial

May 28, 2025

New funds from Nyrada share sales

May 19, 2025

March 2025 Quarterly Activities Report and Appendix 4C

April 29, 2025

Appendix 4D and FY2025 Half Year Financial Report

February 25, 2025

SOF-SKN passes required in vitro safety tests

February 3, 2025

December 2024 Quarterly Activities Report and Appendix 4C

January 28, 2025

Decks in 2025